CRISPR-based pharmacogenomic screening is used most often in ... new ways in which researchers might combat drug resistance and make cancer therapies more effective. Kampmann’s lab is now ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

CRISPR base editing screens have also been used by researchers to map the genetic landscape of drug resistance in cancer. Coelho et al ... they become harder to scale, necessitating screening ...

T-cell therapies where immune cells are genetically engineered to attack specific tumors. In addition, some companies are using CRISPR for screening (which shouldn't be confused with genetic testing).

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Scientists have developed a new system using the CRISPR genome-editing system to attack ...

“CRISPR may be more convenient for gene editing than the prior gene editing tools used.” The study is not the first to use gene editing to interrupt the CCR5 gene in human hematopoietic ...

The team made significant strides in the fight against pediatric cancer by studying tumors ... culture systems for high-throughput drug screening and CRISPR-based functional genomics studies.

The role of tumor suppressors in cancer drug resistance PET-scan of a metastatic melanoma patient who initially responded to therapy but eventually developed resistance. Most of the current targeted ...